WellSpring Consumer Healthcare Acquires DerMend and Recticare from Ferndale Pharma Group

WellSpring Consumer Healthcare Acquires vH essentials from Wisconsin Pharmacal Company

August 1, 2024

Consumer Products

WellSpring Consumer Healthcare, a portfolio company of Avista Healthcare Partners, has acquired the vH essentials women's intimacy care OTC brand from Wisconsin Pharmacal Company. The add-on expands WellSpring's women's health franchise alongside FDS to drive scale and accelerate growth across retail and e-commerce channels; financial terms were not disclosed.

WellSpring Consumer Healthcare Acquires A+D, Solarcaine and Other OTC Skin Care Brands from Bayer

April 4, 2023

Consumer Products

WellSpring Consumer Healthcare, a portfolio company of Avista Capital Partners, acquired a portfolio of OTC skin care brands from Bayer AG — including A+D, Solarcaine, Cortate and Complex 15 — to expand scale, product diversity and accelerate its innovation pipeline. Financial terms were not disclosed; the transaction is described as WellSpring's first add-on acquisition since Avista's investment in August 2022.

Avista Capital Partners Acquires WellSpring Consumer Healthcare

August 23, 2022

Consumer Products

Avista Capital Partners completed the acquisition of WellSpring Consumer Healthcare from Audax Private Equity. WellSpring, founded in 1999 and headquartered in Sarasota, Florida, is a developer and marketer of over-the-counter and personal care brands (including Bactine, Bonine, Emetrol and Glaxal Base); Avista plans to support growth through product innovation, distribution expansion and strategic acquisitions.

Dalrada Health (Sòlas) Acquires Remedi Med Spas

April 12, 2022

Healthcare Services

Dalrada Corporation's Dalrada Health division, operating under the Sòlas Rejuvenation + Wellness group, acquired Remedi Med Spas and its two Southern California locations in Coronado and Mission Hills from Dr. Rakhesh Guttikonda. The acquisition adds two clinics and staff to the North San Diego–based Sòlas platform as part of its regional expansion of wellness and aesthetic services.

NovaBay Pharmaceuticals Acquires DERMAdoctor

September 28, 2021

Consumer Products

NovaBay Pharmaceuticals, Inc. has entered into a definitive agreement to acquire DERMAdoctor, LLC for $15.0 million ( $12.0 million cash at closing plus up to $3.0 million in earnouts). The deal brings DERMAdoctor's ~30-product skincare portfolio and its 13-person team (co-founders Audrey and Jeff Kunin to remain) into NovaBay's commercial platform to expand its presence in the U.S. beauty market and capture revenue and operating synergies.

HRA Pharma Acquires the Mederma Brand from Merz Pharmaceuticals

June 27, 2019

Consumer Products

Laboratoire HRA Pharma SAS has completed the acquisition of the global rights to the Mederma brand (including Mederma, Mederma AG, Eldertonic and Nu‑Iron products) from Merz Pharmaceuticals GmbH; terms were not disclosed. The deal gives HRA Pharma a strong consumer healthcare platform in the United States and supports its strategy to grow its US footprint through organic launches and further targeted acquisitions; Merz said the divestiture sharpens its focus on aesthetics and neurotoxins.